Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 19, 2019 - Issue 11
Submit an article Journal homepage
1,053
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Do biomarkers play a predictive role for response to novel immunotherapeutic agents in metastatic renal cell carcinoma?

Alessandra RaimondiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyView further author information
,
Pierangela SepeDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyView further author information
,
Melanie ClapsDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyView further author information
,
Elena VerzoniDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyView further author information
&
Giuseppe ProcopioDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyCorrespondence[email protected]
View further author information
Pages 1107-1110 | Received 09 May 2019, Accepted 30 Jul 2019, Published online: 06 Aug 2019

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Will Ince & Tim Eisen. (2021) Combination therapies in clinical trials for renal cell carcinoma: how could they impact future treatments?. Expert Opinion on Investigational Drugs 30:12, pages 1221-1229.
Read now
Pierangela Sepe, Alessia Mennitto, Francesca Corti & Giuseppe Procopio. (2020) Immunotherapeutic Targets and Therapy for Renal Cell Carcinoma. ImmunoTargets and Therapy 9, pages 273-288.
Read now

Articles from other publishers (4)

Brian M. Shinder, Shane Kronstedt & A. Ari Hakimi. 2023. Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma. Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma 251 268 .
L. M. Mittlmeier, M. Unterrainer, S. Rodler, A. Todica, N. L. Albert, C. Burgard, C. C. Cyran, W. G. Kunz, J. Ricke, P. Bartenstein, C. G. Stief, H. Ilhan & M. Staehler. (2020) 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results. European Journal of Nuclear Medicine and Molecular Imaging 48:6, pages 2031-2037.
Crossref
Kyrollis Attalla, Stanley Weng, Martin H. Voss & A Ari Hakimi. (2020) Epidemiology, Risk Assessment, and Biomarkers for Patients with Advanced Renal Cell Carcinoma. Urologic Clinics of North America 47:3, pages 293-303.
Crossref
Alessandra Raimondi, Giovanni Randon, Pierangela Sepe, Melanie Claps, Elena Verzoni, Filippo de Braud & Giuseppe Procopio. (2019) The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical Practice. International Journal of Molecular Sciences 20:17, pages 4263.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.